Similar articles for PMID: 24293470

Year	Number of Results
2003	2
2007	3
2008	2
2009	2
2010	2
2011	13
2012	5
2013	21
2014	14
2015	6
2016	8
2017	12
2018	11
2019	4
2020	1
2021	1
2022	1
2024	0

1

Pathogenesis of pulmonary arterial hypertension: lessons from cancer.

Guignabert C, Tu L, Le Hiress M, Ricard N, Sattler C, Seferian A, Huertas A, Humbert M, Montani D. Guignabert C, et al. Eur Respir Rev. 2013 Dec;22(130):543-51. doi: 10.1183/09059180.00007513. Eur Respir Rev. 2013. PMID: 24293470 Free PMC article. Review.

2

New horizons in pulmonary arterial hypertension therapies.

Galiè N, Ghofrani AH. Galiè N, et al. Eur Respir Rev. 2013 Dec;22(130):503-14. doi: 10.1183/09059180.00006613. Eur Respir Rev. 2013. PMID: 24293466 Free PMC article. Review.

3

Lessons from oncology to understand and treat pulmonary hypertension.

Adnot S, Eddahibi S. Adnot S, et al. Int J Clin Pract Suppl. 2007 Dec;(158):19-25. doi: 10.1111/j.1742-1241.2007.01618.x. Int J Clin Pract Suppl. 2007. PMID: 18078390 Review.

4

[The cancer paradigm in pulmonary arterial hypertension: towards anti-remodeling therapies targeting metabolic dysfunction?].

Dumas SJ, Humbert M, Cohen-Kaminsky S. Dumas SJ, et al. Biol Aujourdhui. 2016;210(4):171-189. doi: 10.1051/jbio/2016022. Epub 2017 Mar 22. Biol Aujourdhui. 2016. PMID: 28327277 French.

5

Treatment of pulmonary arterial hypertension with targeted therapies.

O'Callaghan DS, Savale L, Montani D, Jaïs X, Sitbon O, Simonneau G, Humbert M. O'Callaghan DS, et al. Nat Rev Cardiol. 2011 Jul 19;8(9):526-38. doi: 10.1038/nrcardio.2011.104. Nat Rev Cardiol. 2011. PMID: 21769113 Review.

6

The role of vascular endothelial growth factor in pulmonary arterial hypertension. The angiogenesis paradox.

Voelkel NF, Gomez-Arroyo J. Voelkel NF, et al. Am J Respir Cell Mol Biol. 2014 Oct;51(4):474-84. doi: 10.1165/rcmb.2014-0045TR. Am J Respir Cell Mol Biol. 2014. PMID: 24932885 Review.

7

Looking to the future: a new decade of pulmonary arterial hypertension therapy.

McLaughlin VV. McLaughlin VV. Eur Respir Rev. 2011 Dec;20(122):262-9. doi: 10.1183/09059180.00006411. Eur Respir Rev. 2011. PMID: 22130819 Free PMC article. Review.

8

Critical role for the advanced glycation end-products receptor in pulmonary arterial hypertension etiology.

Meloche J, Courchesne A, Barrier M, Carter S, Bisserier M, Paulin R, Lauzon-Joset JF, Breuils-Bonnet S, Tremblay É, Biardel S, Racine C, Courture C, Bonnet P, Majka SM, Deshaies Y, Picard F, Provencher S, Bonnet S. Meloche J, et al. J Am Heart Assoc. 2013 Jan 16;2(1):e005157. doi: 10.1161/JAHA.112.005157. J Am Heart Assoc. 2013. PMID: 23525442 Free PMC article.

9

MicroRNA networks in pulmonary arterial hypertension: share mechanisms with cancer?

Courboulin A, Ranchoux B, Cohen-Kaminsky S, Perros F, Bonnet S. Courboulin A, et al. Curr Opin Oncol. 2016 Jan;28(1):72-82. doi: 10.1097/CCO.0000000000000253. Curr Opin Oncol. 2016. PMID: 26569423 Review.

10

[New insights in the pathogenesis of pulmonary arterial hypertension].

Bordenave J, Tu L, Savale L, Huertas A, Humbert M, Guignabert C. Bordenave J, et al. Rev Mal Respir. 2019 Apr;36(4):433-437. doi: 10.1016/j.rmr.2019.03.003. Epub 2019 Apr 19. Rev Mal Respir. 2019. PMID: 31010759 Free article. Review. French.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

101 results

Results by year